NCT01160081View on ClinicalTrials.gov

Seroprevalence Study of Hepatitis A, Varicella-Zoster, Cytomegalovirus, Herpes Simplex and Bordetella Pertussis

CompletedOBSERVATIONAL
Enrollment

3,658

Participants

Timeline

Start Date

March 31, 2010

Primary Completion Date

September 30, 2010

Study Completion Date

September 30, 2010

Conditions
Viral Hepatitis VaccinesHepatitis ACytomegalovirusVaricella-Zoster VirusBordetella Pertussis InfectionHerpes Simplex (1 and 2)
Interventions
OTHER

Serum sample

Serum samples collected

Trial Locations (1)

Unknown

GSK Investigational Site, Cuernavaca

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY

NCT01160081 - Seroprevalence Study of Hepatitis A, Varicella-Zoster, Cytomegalovirus, Herpes Simplex and Bordetella Pertussis | Biotech Hunter | Biotech Hunter